News

Tuesday, June 10, 2025 – hellocare.ai, a leading AI-assisted virtual care delivery platform transforming hospital care models ...
Atrium Health Wake Forest Baptist Cancer Center-Lexington is beginning a $2.7M expansion of its hematology oncology clinic and infusion center, The Dispatch reported June 10. The expansion will help ...
Medline has continued to expand its national reach through partnerships across hospital systems, ambulatory centers and home care. Here are three recent involving the company: ...
Turnover among chief human resources officers rose 15% globally in the first quarter of 2025 compared to the same period in 2024, according to a recent report from Russell Reynolds Associates. Russell ...
UCSF Children’s Hospital Oakland (Calif.) and its satellite clinics are bracing for an open-ended strike set to begin June 18. Representing more than 1,300 employees, the National Union of Healthcare ...
A federal bill introduced June 10 aims to increase the number of Medicare-supported medical residency positions by 14,000 over seven years. Five things to know: 1. The Association of American Medical ...
Mark Cuban’s Cost Plus Drugs Co. has expanded operations across its drug manufacturing, distribution and partnership enterprises. The company continues to grow its presence in the generic drug market ...
It’s a changing world — and marketplace — for health and wellness providers. Mergers and acquisitions mean private equity firms are gaining an increasing share of the marketplace.1 And more and more ...
Despite rising operational costs and an evolving healthcare landscape, several health systems rebounded with strong financial performances in the first quarter of 2025. Below are 15 health systems ...
Oregon Gov. Tina Kotek has signed a bill into law that sets the nation’s strictest regulations on private and corporate control of medical practices, the Oregon Capital Chronicle reported June 9.
The American Pharmacists Association is withholding its endorsement of the latest adult immunization schedule issued by the CDC’s Advisory Committee on Immunization Practices. After recent updates by ...
The FDA has approved a revised label for Merck’s immunotherapy drug Keytruda, limiting its use in some gastrointestinal cancer treatments to patients whose tumors express a minimum level of PD-L1 ...